Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mas Esteve (Lleida, Spain), D. Polanco Alonso (Lleida, Spain), S. Bertran Melines (Lleida, Spain), G. Fierro Barrabés (Lleida, Spain), E. Galera Lozano (Lleida, Spain), A. Seminario Ruíz (Lleida, Spain), G. Suárez Cuartin (Lleida, Spain), S. Gómez Falguera (Lleida, Spain), M. Vilà Justribó (Lleida, Spain), F. Barbé Illa (Lleida, Spain). Time in lung cancer diagnosis and its prognostic implication. 2829

Member's Comments

No comment yet.

Related content which might interest you: Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer? Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Brain metastasis as initial presentation of lung cancer - Impact of prognostic factors on patient survival Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Prognostic relevance of the new lung cancer classification in operable stages Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science Year: 2014 Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Time lost for diagnostics of lung carcinoma related to disease stage and prognosis Source: Eur Respir J 2004; 24: Suppl. 48, 297s Year: 2004 Identification of genes with diagnostic and prognostic value in lung cancer. Source: International Congress 2019 – Biology of lung cancer Year: 2019 Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001 Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017 Year: 2018 Prognostic factors in patients with lung cancer and brain metastases at presentation Source: Eur Respir J 2007; 30: Suppl. 51, 670s Year: 2007 Prognostic parameters in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006 Clinicopathological prognostic factors in operated for lung cancer and brain metastasis patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Candidacolonization in lung cancer patients and its role as a prognostic factor for infection occurrence during hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 433s Year: 2003 Lung cancer patient evaluation of performance status as a prognostic factor Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The role of molecular pathology in diagnosis and treatment of lung cancer Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases Year: 2007